A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy
NCT05875974
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
207
Enrollment
INDUSTRY
Sponsor class
Conditions
Idiopathic Hypersomnia
Narcolepsy
Interventions
DRUG:
JZP258 (XYWAV)
Sponsor
Jazz Pharmaceuticals